Progenics Pharmaceuticals Inc (PGNX) Return on Investment ROI from the first quarter of 2020 to first quarter of 2019 and for the year 2020, average high and low, overall ranking from Mar 31 2020 to Mar 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Progenics Pharmaceuticals Inc  (PGNX)


Progenics Pharmaceuticals Inc's ROI from its first quarter of 2020 to the first quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Progenics Pharmaceuticals Inc's ROI in the first quarter of 2020?
Progenics Pharmaceuticals Inc recorded a cumulative net loss of $-67 million during 12 months ending in the first quarter of 2020, resulting in a negative return on investment (ROI) of -66.5%.

Within the Healthcare sector 537 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2019 from 0 to 3982.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Investment Change TTM -29.03 % -21.14 % -7.36 % 7.92 % 2.5 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 79 82 110 129 125
Return On Investment (TTM) -66.5 % -61.42 % -56.44 % -54.76 % -51.69 %
PGNX's Overall Ranking # 3982 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -10.24 % -12.48 % -9.89 % 0.26 % -0.25 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -67 -69 -72 -77 -73

PGNX Company Profile >> Back to PGNX Roi Comparisons >> See Annual PGNX Return On Investment



Return On Investment PGNX's Ranking
Within: No.
Industry # 246
Sector # 538
Overall # 3982

Return On Investment Statistics
High Average Low
9.32 %
-26.96 %
-64.09 %
(Sep 30 2016)   (Mar 31 2020)







Financial Statements
Progenics Pharmaceuticals Inc's I. Quarter Investments $ 79 Millions PGNX's Balance sheet
Progenics Pharmaceuticals Inc's I. Quarter Income $ -17 Millions Quarterly PGNX's Income Statement
PGNX's Income by Division See PGNX's Income by Division


PGNX Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 82 146 131 183 122
Y / Y Investment Growth -43.61 % 11.83 % -28.49 % 50.03 % -21.14 %
Net Income in Millions -69 -68 -51 11 -39
Y / Y Net Income Growth - - - - -
Annual Return On Investment -83.23 % -46.32 % -39.06 % 5.88 % -32.14 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PGNX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PGNX's Competitors
Subscribers only: Roi for Progenics Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for PGNX's Customers

Other Ratios
PGNX's Roa PGNX's Inventory Turnover Ratio PGNX's Growth Rates PGNX's Dividend Statistics
PGNX's Profitability Ratios PGNX's Asset Turnover Ratio PGNX's Dividend Growth
PGNX's Roe PGNX's Valuation Ratios PGNX's Financial Strength Ratios PGNX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2020, within Healthcare Sector ROI

Date modified: 2026-09-08T15:09:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.